These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36806511)

  • 21. Altered Expression Profile of Phosphatidylinositols in Erythrocytes of Alzheimer's Disease and Amnestic Mild Cognitive Impairment Patients.
    Chen Y; Lin C; Guo Z; Zhao S; Zhu Y; Huang F; Shui G; Lam SM; Pu J; Yan Y; Liu Z; Zhang B
    J Alzheimers Dis; 2020; 73(2):811-818. PubMed ID: 31868671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Kobayashi N; Shinagawa S; Nagata T; Shimada K; Shibata N; Ohnuma T; Kasanuki K; Arai H; Yamada H; Nakayama K; Kondo K
    PLoS One; 2016; 11(12):e0168816. PubMed ID: 27992572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
    Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
    Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
    Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
    [No Abstract]   [Full Text] [Related]  

  • 26. Multimodal Classification of Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Integrated 18F-FDG PET and DTI Study.
    Li W; Zhao Z; Liu M; Yan S; An Y; Qiao L; Wang G; Qi Z; Lu J
    J Alzheimers Dis; 2022; 85(3):1063-1075. PubMed ID: 34897092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.
    Moreno-Grau S; Rodríguez-Gómez O; Sanabria Á; Pérez-Cordón A; Sánchez-Ruiz D; Abdelnour C; Valero S; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Lafuente A; Gil S; Santos-Santos MÁ; Alegret M; Espinosa A; Ortega G; Guitart M; Gailhajanet A; de Rojas I; Sotolongo-Grau Ó; Ruiz S; Aguilera N; Papasey J; Martín E; Peleja E; ; Lomeña F; Campos F; Vivas A; Gómez-Chiari M; Tejero MÁ; Giménez J; Serrano-Ríos M; Orellana A; Tárraga L; Ruiz A; Boada M;
    Alzheimers Dement; 2018 May; 14(5):634-643. PubMed ID: 29156223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive classification models based on amygdala radiomic features for Alzheimer's disease and mild cognitive impairment.
    Feng Q; Niu J; Wang L; Pang P; Wang M; Liao Z; Song Q; Jiang H; Ding Z
    Brain Imaging Behav; 2021 Oct; 15(5):2377-2386. PubMed ID: 33537928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease.
    Kobayashi N; Shinagawa S; Niimura H; Kida H; Nagata T; Tagai K; Shimada K; Oka N; Shikimoto R; Noda Y; Nakajima S; Mimura M; Shigeta M; Kondo K
    Sci Rep; 2020 Jul; 10(1):12217. PubMed ID: 32699290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
    Wolk DA; Sadowsky C; Safirstein B; Rinne JO; Duara R; Perry R; Agronin M; Gamez J; Shi J; Ivanoiu A; Minthon L; Walker Z; Hasselbalch S; Holmes C; Sabbagh M; Albert M; Fleisher A; Loughlin P; Triau E; Frey K; Høgh P; Bozoki A; Bullock R; Salmon E; Farrar G; Buckley CJ; Zanette M; Sherwin PF; Cherubini A; Inglis F
    JAMA Neurol; 2018 Sep; 75(9):1114-1123. PubMed ID: 29799984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative Brain Amyloid Measures Predict Time-to-Progression from Amnestic Mild Cognitive Impairment to Alzheimer's Disease.
    Jun S; Kim H; Kim BS; Yoo BG; Lee WG;
    J Alzheimers Dis; 2019; 70(2):477-486. PubMed ID: 31256127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent Connectivity Changes in Gray Matter Structural Covariance Networks in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; He Y; Wang X; Lu J; Li S; Li X; Kang G; Han Y; Li S
    Front Aging Neurosci; 2021; 13():686598. PubMed ID: 34483878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
    Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
    Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential associations of visual memory with hippocampal subfields in subjective cognitive decline and amnestic mild cognitive impairment.
    Huang Y; Huang L; Wang Y; Liu Y; Lo CZ; Guo Q
    BMC Geriatr; 2022 Feb; 22(1):153. PubMed ID: 35209845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Speech silence character as a diagnostic biomarker of early cognitive decline and its functional mechanism: a multicenter cross-sectional cohort study.
    Wang HL; Tang R; Ren RJ; Dammer EB; Guo QH; Peng GP; Cui HL; Zhang YM; Wang JT; Xie XY; Huang Q; Li JP; Yan FH; Chen SD; He NY; Wang G
    BMC Med; 2022 Nov; 20(1):380. PubMed ID: 36336678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment.
    Shao W; Li X; Zhang J; Yang C; Tao W; Zhang S; Zhang Z; Peng D
    Eur J Neurol; 2019 May; 26(5):800-807. PubMed ID: 30584694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild Cognitive Impairment in Peripheral Blood.
    Wang T; Zhang W; Maclin JMA; Xu H; Hong B; Yan F; Liu Y; He H; Liang H; Li C; Fang Y; Xiao S
    J Alzheimers Dis; 2024; 99(4):1385-1396. PubMed ID: 38788072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer's Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry.
    Li K; Qu H; Ma M; Xia C; Cai M; Han F; Zhang Q; Gu X; Ma Q
    Front Aging Neurosci; 2022; 14():816043. PubMed ID: 35547625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors and Neuropsychological Assessments of Subjective Cognitive Decline (
    Hao L; Xing Y; Li X; Mu B; Zhao W; Wang G; Wang T; Jia J; Han Y
    Front Neurosci; 2019; 13():846. PubMed ID: 31474820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.